Protalix Biotherapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $118k | 53k | 2.22 |
| 2025-06-30 | $16k | 11k | 1.48 |
| 2025-03-31 | $219k | 86k | 2.56 |
| 2024-12-31 | $361k | 192k | 1.88 |
| 2024-09-30 | $180k | 176k | 1.02 |
| 2024-06-30 | $92k | 78k | 1.17 |
| 2024-03-31 | $77k | 61k | 1.26 |
| 2023-12-31 | $185k | 104k | 1.78 |
| 2023-09-30 | $194k | 117k | 1.66 |
| 2023-06-30 | $338k | 169k | 2.00 |
| 2023-03-31 | $688k | 328k | 2.10 |
| 2022-12-31 | $264k | 193k | 1.37 |
| 2022-06-30 | $0 | 110k | 0.00 |
| 2022-03-31 | $51k | 47k | 1.10 |
| 2021-12-31 | $64k | 78k | 0.83 |
| 2021-09-30 | $280k | 203k | 1.38 |
| 2021-06-30 | $701k | 367k | 1.91 |
| 2021-03-31 | $367k | 82k | 4.47 |
| 2020-12-31 | $87k | 24k | 3.61 |
| 2020-09-30 | $83k | 22k | 3.86 |
| 2020-06-30 | $137k | 36k | 3.84 |